v3.26.1
STOCK-BASED AND OTHER COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted Common Stock Award
June 30, 2026December 31, 2025
Number of SharesWeighted
Average
Grant Price
Number of SharesWeighted
Average
Grant Price
Restricted Shares
Unvested and outstanding at beginning of year6,109 $12.36 39,171 $12.48 
Granted6,500 20.63 — — 
Issued and vested(6,109)12.36 (33,062)12.50 
Forfeited— — — — 
Unvested and outstanding at end of period6,500 $20.63 6,109 $12.36 

June 30, 2026
Number of SharesWeighted
Average
Grant Price
Performance Based Restricted Shares
Unvested at beginning of year18,321 $12.36 
2023 performance shares below target(7,141)12.36 
Issued and vested(11,180)12.36 
Unvested at end of period— $— 
December 31, 2025
Number of SharesWeighted
Average
Grant Price
Performance Based Restricted Shares
Unvested at beginning of year33,188 $13.09 
2022 performance shares granted above target1,154 14.00 
Issued and vested(16,021)14.00 
Unvested at end of period18,321 $12.36 
Schedule of Common Stock Option Awards
Option SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term in Years
Aggregate
Intrinsic
Value
June 30, 2026
Outstanding at beginning of year35,500 $11.98 
Exercised(21,000)10.79 
Outstanding at end of period14,500 $13.69 1.23$141 
Exercisable at end of period14,500 $13.69 1.23$141 
December 31, 2025
Outstanding at beginning of year52,00011.62
Exercised(16,500)10.84
Outstanding at end of year35,50011.981.06207
Exercisable at end of year35,500 $11.98 1.06$207 
Schedule of Information Related to Stock Option Plan
Information related to the 2008 Equity Incentive Plan for the respective periods follows:
Six months ended June 30, 2026Twelve months ended December 31, 2025
Intrinsic value of options exercised$197 $84 
Cash received from options exercised$227 $179 
Tax benefit realized from options exercised$— $—